YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease
Research output: Contribution to journal › Journal article › Research › peer-review
YKL-40 is involved in remodelling and angiogenesis in non-cardiac inflammatory diseases. Aim was to quantitate plasma YKL-40 in patients with ST-elevation myocardial infarction (STEMI) or stable chronic coronary artery disease (CAD), and YKL-40 gene activation in human myocardium.
Original language | English |
---|---|
Journal | Scandinavian Cardiovascular Journal |
Volume | 42 |
Issue number | 5 |
Pages (from-to) | 295-302 |
Number of pages | 8 |
ISSN | 1401-7431 |
DOIs | |
Publication status | Published - Oct 2008 |
Externally published | Yes |
- Acute Coronary Syndrome, Adipokines, Aged, Biological Markers, Case-Control Studies, Coronary Artery Disease, Female, Gene Expression, Glycoproteins, Humans, Lectins, Male, Middle Aged
Research areas
ID: 47743805